Emily Weng

Bimatoprost for Eyelash Growth in Japanese Subjects: Two Multicenter Controlled Studies

S. Arase, K. Harii, A. Vandenburgh, 2014, Aesthetic Plastic Surgery.

Eyelash growth in subjects treated with bimatoprost: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study.

S. Whitcup, S. Fagien, Stacy R. Smith, 2012, Journal of the American Academy of Dermatology.

Bimatoprost 0.03% for the Treatment of Eyebrow Hypotrichosis

J. Carruthers, Z. Draelos, S. Whitcup, 2016, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Safety and Efficacy of Bimatoprost for Eyelash Growth in Postchemotherapy Subjects.

L. Baumann, D. Wirta, S. Bruce, 2015, The Journal of clinical and aesthetic dermatology.

Long‐term safety and efficacy of bimatoprost solution 0·03% application to the eyelid margin for the treatment of idiopathic and chemotherapy‐induced eyelash hypotrichosis: a randomized controlled trial

P. Hossain, W. Perkins, T. Griffiths, 2015, The British journal of dermatology.

Long-term safety evaluation of bimatoprost ophthalmic solution 0.03%: a pooled analysis of six double-masked, randomized, active-controlled clinical trials

S. Whitcup, D. Wirta, A. Vandenburgh, 2011, Clinical ophthalmology.

Patient-reported outcomes of bimatoprost for eyelash growth: results from a randomized, double-masked, vehicle-controlled, parallel-group study.

J. Carruthers, S. Cox, J. Walt, 2013, Aesthetic surgery journal.

Efficacy and safety of oxymetazoline cream 1.0% for treatment of persistent facial erythema associated with rosacea: Findings from the 52‐week open label REVEAL trial

L. Baumann, Z. Draelos, M. Gold, 2018, Journal of the American Academy of Dermatology.

Intraperitoneal and Extraperitoneal Colonic Perforation Following Diagnostic and Therapeutic Colonoscopy with Crohn’s-related Stricture Dilation

D. Valencia, Median Ali, Emily Weng, 2020, Cureus.

Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the First REVEAL Trial.

Z. Draelos, L. Kircik, K. Grande, 2018, Journal of drugs in dermatology : JDD.